Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00346827
Recruitment Status : Unknown
Verified June 2006 by Britannia Pharmaceuticals Ltd.. Recruitment status was: Not yet recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 85 Years (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
1 year history of Parkinson's Disease; stable PD medications for 4 weeks; at least one documented "off" period per day
hypersensitivity to apomorphine; participation in a clinical trial in the last 12 weeks; pregnant or lactating females